http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-082631-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 |
| filingDate | 2011-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-082631-A1 |
| titleOfInvention | DERIVATIVES OF 2,8-DIAZA-ESPIRO [4,5] DECAN-1-ONA, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, PROCESS TO PREPARE THEM AND USE OF THEM TO TREAT DIABETES, OBESITY, DYSLIPEMIA AND METABOLIC SYNDROME |
| abstract | Claim 1: Compounds of the formula (1) wherein R1 is imidazolyl, pyrazolyl, triazolyl, phenyl, pyridinyl, pyrazinyl, pyrimidyl, pyridazinyl or 2-oxo-1,2-dihydro-pyridinyl or this is selected from imidazolyl , pyrazolyl, triazolyl, phenyl, pyridinyl pyrazinyl pyrimidyl, pyridazinyl and 2-oxo-1,2-dihydro-pyridinyl, which are substituted with one to three substituents, independently selected from alkyl, cycloalkyl, alkylcycloalkyl, cycloalkylalkyl, cycloalkylalkoxy, cycloalkylalkoxyalkyl, cycloalkoxy, cycloalkoxyalkyl, alkylcycloalkylalkyl, halocycloalkyl, halocycloalkylalkyl, halogen, haloalkyl, hydroxy, hydroxyalkyl, alkoxy, alkoxyalkyl, haloalkoxy, hydroxyalkoxy, alkoxyalkoxy, alkoxyalkyl alkoxyalkyl; R2, is imidazolyl, pyrazolyl, triazolyl, phenyl, pyridinyl, pyrazinyl, pyrimidyl, pyridazinyl or 2-oxo-1,2-dihydro-pyridinyl, or this is selected from imidazolyl, pyrazolyl, triazolyl, phenyl, pyridinyl, pyrazinyl pyrimidyl, pyridazinyl and 2-oxo-1,2-dihydro-pyridinyl, which are substituted with one to three substituents, independently selected from alkyl, cycloalkyl, alkylcycloalkyl, cycloalkylalkyl, cycloalkylalkoxy, cycloalkylalkoxyalkyl, cycloalkoxy, cycloalkoxyalkyl, alkylcycloalkyloalkyl, haloalkyl, haloalkyl , halogen, haloalkyl, hydroxy, hydroxyalkyl, alkoxy, alkoxyalkyl, haloalkoxy, hydroxyalkoxy, alkoxyalkoxy, alkoxyalkoxyalkyl, hydroxyhaloalkyl and benzyloxy; n, is zero, 1, 2 or 3; and pharmaceutically acceptable salts thereof. |
| priorityDate | 2010-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.